Sun Pharmaceutical Industries Company Description
Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations and active pharmaceutical ingredients (APIs) in India and internationally.
The company offers formulations in various therapeutic areas, including central nervous system, dermatology, cardiology, oncology, neuropsychiatry, gastroenterology, anti-infectives, diabetology, pain/analgesics, vitamins/minerals/nutrients, respiratory, gynaecology, urology, ophthalmology, orthopaedic, nephrology, dental, and other areas.
It provides APIs for anti-cancers, peptides, steroids, hormones, and immunosuppressant drugs. In addition, the company offers generic medications, such as tablets, capsules, injectables, inhalers, ointments, creams, and liquids; speciality medications, and antiretrovirals medications, as well as over-the-counter products.
The company was founded in 1983 and is headquartered in Mumbai, India.
Country | India |
Founded | 1983 |
Industry | Pharmaceutical Preparations |
Employees | 43,000 |
CEO | Dilip Shanghvi |
Contact Details
Address: Sun House Mumbai, Gujarat 400063 India | |
Phone | 91 22 4324 4324 |
Website | sunpharma.com |
Stock Details
Ticker Symbol | 524715 |
Exchange | Bombay Stock Exchange |
Fiscal Year | April - March |
Reporting Currency | INR |
SIC Code | 2834 |
Key Executives
Name | Position |
---|---|
Dilip Shanghvi | Chief Executive Officer |
C. Muralidharan | Chief Financial Officer |
Davinder Singh | Chief Operating Officer |
Abhishek Sharma | Head of Investor Relations |